Characterization of interstitial pneumonia in anti Jo-1 antibody positive patients with polymyositis/dermatomyositis.

被引：0
|
作者：
Yamasaki, M
Yamasaki, Y
Yamada, H
Niimi, H
Kurihara, Y
Hama, N
Ichikawa, Y
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
762
引用
收藏
页码：S193 / S193
页数：1
相关论文
共 50 条
  • [31] Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients
    Vancsa, Andrea
    Csipo, I.
    Nemeth, J.
    Devenyi, K.
    Gergely, L.
    Danko, K.
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (09) : 989 - 994
  • [32] Characterization of Jo-1 specific T cell proliferative responses in polymyositis.
    Ascherman, DP
    Oriss, TB
    Wright, TM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S263 - S263
  • [33] Bronchiolitis obliterans with organizing pneumonia (BOOP) heralding anti-Jo-1-positive polymyositis
    Xing, MZ
    Lansdale, TF
    McNamara, CF
    Hauptman, HW
    Tao, L
    Kantor, R
    Pabla, R
    Shenoy, G
    Obah, EA
    Bedon, G
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1999, 5 (04) : 219 - 223
  • [34] Prediction for responsiveness of interstitial pneumonia in dermatomyositis and polymyositis patients to corticosteroid therapy
    Ikeda, K
    Kurasawa, K
    Miike, S
    Nakajima, H
    Nakagawa, N
    Takiguchi, Y
    Kuriyama, T
    Iwamoto, I
    Saito, Y
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 67 - 68
  • [35] Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
    Yamasaki, Y.
    Yamada, H.
    Yamasaki, M.
    Ohkubo, M.
    Azuma, K.
    Matsuoka, S.
    Kurihara, Y.
    Osada, H.
    Satoh, M.
    Ozaki, S.
    RHEUMATOLOGY, 2007, 46 (01) : 124 - 130
  • [36] Anti-Jo1 Antibody in Polymyositis/dermatomyositis Is Still Closely Associated with Lung rather than Joints
    Jearn, La-He
    Kim, Think-You
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 1060 - 1060
  • [37] Successful therapy of anti-Jo-1 antibody positive polymyositis with leflunomide and a current overview
    Piegsa, M
    Strunk, J
    Lange, U
    Müller-Ladner, U
    AKTUELLE RHEUMATOLOGIE, 2005, 30 (04) : 238 - 244
  • [38] Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients
    Fujiki, Youhei
    Kotani, Takuya
    Isoda, Kentaro
    Ishida, Takaaki
    Shoda, Takeshi
    Yoshida, Shuzo
    Takeuchi, Tohru
    Makino, Shigeki
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 133 - 140
  • [39] Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis
    Fujita, J
    Dobashi, N
    Tokuda, M
    Bandoh, S
    Ohtsuki, Y
    Yamadori, I
    Yoshinouchi, T
    Ueda, Y
    Takahara, J
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (11) : 2377 - 2382
  • [40] Clinical Features and Outcome In Polymyositis Vs. Dermatomyositis Patients With The Anti-Jo-1 Autoantibody
    Aggarwal, Rohit
    Koontz, Diane
    Qi, Zengbiao
    Oddis, Chester V.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S879 - S880
12345